This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignee: Blueprint Medicines Corporation. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Philip D Ramsden: Innovator in Cancer Treatment
Introduction
Philip D Ramsden is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 4 patents, Ramsden has focused on creating compounds that can potentially improve patient outcomes in oncology.
Latest Patents
Ramsden's latest patents include advancements in CDK2 inhibitors. The present disclosure provides a compound represented by structural Formula (I) or a pharmaceutically acceptable salt thereof, which is useful for treating cancer. This innovative approach aims to target specific pathways involved in cancer progression, offering new hope for effective treatments.
Career Highlights
Throughout his career, Ramsden has been associated with Blueprint Medicines Corporation, where he has played a crucial role in the development of novel therapeutic agents. His work has been instrumental in advancing the understanding of cancer biology and the development of targeted therapies.
Collaborations
Ramsden has collaborated with esteemed colleagues such as Douglas Wilson and Neil Bifulco. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in cancer treatment.
Conclusion
Philip D Ramsden is a dedicated inventor whose work in CDK2 inhibitors represents a significant advancement in cancer therapy. His contributions continue to impact the field positively, paving the way for future innovations in oncology.